The Government Accountability Office (GAO) has released a new study on prescription drug use to treat obesity.

Several physician members of American Association of Clinical Endocrinologists (AACE) — including Dr. W. Timothy Garvey, Dr. Ken Fuijoka, and Dr. Ania Jastreboff — participated in the study’s development and report.


The CDC recently launched in collaboration with Google Health, a prediabetes quiz that will pop up when end users search for certain medical information using their Google browser to bring more public awareness about prediabetes.


Medicare imposed substantial cuts in reimbursements for the new and revised fine needle aspiration codes for 2019. AACE, together with the Endocrine Society and American Thyroid Association, advocated for you with letters to Centers for Medicare and Medicaid Services (CMS) and Congress opposing these cuts. We secured a win with the release of the proposed physician pay rule issued July 29. 


In this webinar, attorneys Robert Liles and Paul Weidenfeld will discuss EKRA, the Anti-Kickback Statue and State All Payor Rules along with steps your practice should take to stay out of trouble. This webinar is scheduled for 60 minutes with a Q and A session to follow.


Join Liles Parker Attorneys Leonard Schneider and Jennifer Papapanagiotou for this webinar, scheduled for 60 minutes with a Q & A session to follow. Registration is free.


Use the tools to assist obese patients from diagnosis to treatment and management.
Use the url below to link to the tool kit.

Nutrition and Obesity toolkit


August 1, 2019

Commercial Carrier Update

AACE Practice Management has gathered the latest news from commercial carriers to help endocrinologists and their practices. For more information, please e-mail practicemanagement@aace.com.


To help assist endocrinologists and staff, AACE Practice Management has gathered the latest about compliance, audits and areas of risk for your practice. For more information, please e-mail practicemanagement@aace.com.


AACE Practice Management has gathered the latest information for correct coding, coverage determinations and prior authorizations to help in the management of your practice. Take advantage of coding and billing webinars throughout the year from AACE partners Practice Management Institute (PMI) and Liles Parker: click here to learn more. For more information, please e-mail practicemanagement@aace.com.


AACE Practice Management has gathered the latest news from the Centers of Medicare & Medicaid Services to help endocrinologists and their practices. For more information, please e-mail practicemanagement@aace.com.


The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes proposals to update payment policies, payment rates, and quality provisions for services furnished under the Medicare Physician Fee Schedule (PFS) on or after January 1, 2020.


The nomination period is NOW OPEN for the 2020 AACE/ACE Awards. AACE Members may nominate colleagues to recognize the extraordinary accomplishments and exceptional contributions of leaders in our field.


Medscape reports the nasal powder, used in the treatment of severe hypoglycemia for patients aged 4 years or older, is the first licensed glucagon product that is not delivered by injection and that does not require a multistep mixing process.


The FACE application period is from Monday, August 12, 2019, 8:00 am ET to Friday, November 01, 2019, 5:00 pm, ET. FACE Applications for 2020 will only be accepted through an online process.


Prasad, M. et al. Triglyceride and Triglyceride/HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease. J Am Heart Assoc. 2019;8:e009442. DOI: 10.1161/JAHA.118.009442.)


Chait, A. and Eckel, R. The Chylomicronemia Syndrome Is Most Often Multifactorial. Ann Intern Med. 2019;170:626-634. doi:10.7326/M19-0203


Arnett DK, Blumenthal RS, Albert MA et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation 2019:Cir0000000000000678


Hawley CE, et al. Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines. Drugs Aging 2019


Kim DW, et al. Association between statin treatment and new-onset diabetes mellitus: a population based case-control study. Diabetology & metabolic syndrome 2019; 11:30


Schleyer T, Hui S, Wang J, et al. Quantifying unmet need in statin-treated hyperlipidemia patients and the potential benefit of further LDL-C reduction through an EHR-based retrospective cohort study. J Manag Care Spec Pharm. 2019;25(5):544-554. 


Presenting PrescriptionHelp.aace.com – A directory of prescription affordability programs and resources for your endocrine patients to help them acquire the medications they need at reduced out-of-pocket costs.


In the systematic review and meta-analysis of more than 4,000 patients with adenomas published in the Annals of Internal Medicine (Elhassan et al), authors reported that patients with mild autonomous cortisol secretion or nonfunctioning adrenal adenomas very rarely develop overt hormonal excess (<0.1%). In addition, adenoma growth >1cm occurred only in 2.5% of patients and no patient developed an adrenal malignancy at follow up.


The U.S. Food and Drug Administration is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks.


The QPP Submissions API will only accept requests and return responses in QPP JSON format. This means that files must be uploaded to the QPP website in either QPP JSON or QRDA III XML.


The Centers for Medicare & Medicaid Services (CMS) has contracted with Guidehouse to conduct data validation and audits of a select number of Merit-based Incentive Payment System (MIPS) eligible clinicians. Data validation and audits are processes that will help ensure MIPS is operating with accurate and useful data. MIPS eligible clinicians, groups and virtual groups are required by regulation to comply with data sharing requests, providing all data as requested by CMS.


The American Association of Clinical Endocrinologists (AACE), a professional community of physicians specializing in endocrinology, diabetes, and metabolic disorders, completed its latest phase of digital transformation by launching a new association management system, and content management system that will provide improved operational efficiency for the organization and an enhanced online experience for the endocrine community.


Working with health care professionals and leaders across the country, the new position statement improves patient care.


JUNE 18–19, 2019 | 1:00-3:30 pm ET | These interactive training webinars by the Centers for Medicare & Medicaid Services are stand-alone events covering Medicare Program basics. You aren’t required to attend both days, and space is limited.


When it comes to optimal bone health and fracture prevention, there is scant evidence for recommending supplementation with vitamins and minerals other than calcium and vitamin D, according to AACE member Daniel L. Hurley, MD, FACE, who spoke at the AACE 28th Annual Scientific & Clinical Congress.


This year, at the 28th Annual Scientific & Clinical Congress, AACE made changes to the traditional lecture format and pushed for casual presentations, allowing more in-depth and interactive conversations. Read about the change from a member's perspective in this editorial by Archana Sadhu, MD, FACE, longtime Los Angeles resident.


Findings presented at the AACE 28th Annual Scientific & Clinical Congress showed that seeking hospital care for diabetic ketoacidosis during the weekend as opposed to during the week may increase mortality risk.


The Centers for Medicare and Medicaid Services (CMS) has posted the following new resources to the Quality Payment Program (QPP) Resource Library, including the 2019 MIPS Eligibility Decision Tree, specialty guides, and eligibility redetermination fact sheet.


The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (RFI) seeking new ideas from the public on how to continue the progress of the Patients over Paperwork initiative. Since launching in fall 2017, Patients over Paperwork has streamlined regulations to significantly cut the “red tape” that weighs down our healthcare system and takes clinicians away from their primary mission—caring for patients. 


The Quality Payment Program (QPP) is creating more ways for developers to build software that integrates directly with CMS applications and data. As part of that initiative, the Quality Payment Program Developer Tools now includes information on how to programmatically interact with eligibility data via the Eligibility Application Programming Interface (API).


Type 2 diabetes (T2D) is associated with increased risk for fractures in the short term but not in the long term, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Treatment with linagliptin in patients with type 2 diabetes (T2D) and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events or hospitalization for heart failure, according to results of the CARMELINA study (Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus) presented at the AACE 28th Annual Scientific & Clinic


Abaloparatide followed by alendronate treatment may improve bone mineral density (BMD) in women with postmenopausal osteoporosis and type 2 diabetes (T2D), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


The use of an insulin pump to deliver continuous pulsatile cortisol may be a viable treatment option in patients with severe adrenal insufficiency who are unresponsive to oral corticosteroids, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Biochemical markers and clinical signs and symptoms of endogenous Cushing syndrome improved after 6 months of levoketoconazole therapy, according to phase 3 study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Significantly more euthyroid patients with thyroid disease suffer from anxiety compared with depression, regardless of whether they have Hashimoto thyroiditis autoimmunity, according to research results presented at the AACE 28th Annual Scientific & Clinical Congress. 


A weighted cardiometabolic disease staging risk score can be used to quantify race- and sex-specific type 2 diabetes risk in a large, diverse population, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Hypothyroidism is a risk factor for increased length of hospital stay and mortality in patients with congestive heart failure (CHF), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Teprotumumab effectively reduces proptosis in patients with active thyroid eye disease, according to phase 3 confirmatory trial data presented at the AACE 28th Annual Scientific & Clinical Congress.


For indeterminate thyroid nodules following fine needle aspiration, evidence of thick post-microcystic reflection on ultrasound was found to be associated with malignant nodules, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Lower income and education levels may negatively affect the experience and expectations of patients who are obese who receive care for weight management, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


The cardiovascular and renal effects of treatment with canagliflozin in patients with type 2 diabetes are more prominent in patients not taking metformin compared with patients treated with canagliflozin as an add-on to metformin, according to data from the CANVAS (CANagliflozin cardioVascular Assessment Study) Program presented at the AACE 28th Annual Scientific & Clinical Congress.


Endocrine Today has compiled a list of the top five news stories posted from the American Association of Clinical Endocrinologists Scientific & Clinical Congress, held April 24-28, 2019, in Los Angeles.


Distinctive serum steroid profiles might emerge in patients with adrenal tumors and Cushing's syndrome, according to research reported by Shobana Athimulam, MBBS, of the Mayo Clinic in Rochester, Minnesota, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The ThyroSeq v3 Genomic Classifier was able to effectively classify thyroid nodules with samples collected through fine needle aspiration (FNA), according to research reported by Lindsey Tolino, MBA, of the University of Pittsburgh Medical Center in Pennsylvania, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The investigational agent teprotumumab was effective for reducing proptosis associated with thyroid eye disease, according to late-breaking phase III data presented by Raymond Douglas, MD, PhD, of Cedars Sinai Medical Center in Los Angeles, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The investigational agent relacorilant significantly improved excess cortisol in patients with endogenous hypercortisolism, researchers reported at the AACE 28th Annual Scientific & Clinical Congress.


Among patients on hemodialysis, trabecular bone score was helpful in predicting fracture risk, researchers reported during an oral presentation of the findings at AACE’s 28th Annual Scientific & Clinical Congress.


AACE Member Roy Taylor, MD, discussed the pathogenesis of hepatic insulin resistance in people with type 2 diabetes in an interview at AACE’s 28th Annual Scientific & Clinical Congress.


AACE Member Felicia Cosman, MD, professor of medicine at Columbia University, New York, discussed the current state of osteoporosis treatment in an interview at AACE’s 28th Annual Scientific & Clinical Congress.


Lewis E. Braverman, MD, MACE, 89, passed away peacefully on Monday, June 10, 2019. He leaves his wife Mimi Braverman; his sons, William Braverman and Daniel Braverman; and his five grandchildren.


CR 11003 introduced the enrollment process for the providers who intend to get their Additional Documentation Request (ADR) letters electronically (as eMDR) through their registered Health Information Handler. Make sure your billing staffs are aware of these changes.


The AACE/ACE My Diabetes Emergency Plan program helps people with diabetes prepare for emergency situations or natural disasters that could disrupt daily routines and limit access to needed diabetes medications and supplies.
With the 2019 Hurricane Season officially underway, it's particularly urgent that people with diabetes have a plan and evacuation kits ready.


Winners Selected Among Nearly 500 e-Posters Presented at AACE 2019


Professional Physician Organization Elects New Officers at AACE 2019


Recent research findings from Teprotumumab and CREDENCE to be presented in the US for first time


Recipients Will Be Honored at the AACE 2019 Conference


Conference will focus on best practices for enhancing endocrine patient care, feature keynote speaker and social media expert Kevin Pho, M.D.


Kevin Pho, MD, is a board-certified internal medicine physician and founder of KevinMD, social media’s leading physician voice. He has been named the web’s top social media influencer in health care and medicine. Dr. Pho is coming to AACE to deliver the keynote address “Social Media and the Physician” on Saturday, April 27. AACE2019News.com recently had the opportunity to ask Dr. Pho a few questions about his presentation, social media and why endocrinologists should get on the social media train.


The American Association of Clinical Endocrinologists (AACE) announced today the publication of the AACE/ACE 2019 Comprehensive Type 2 Diabetes Management Algorithm.


JACKSONVILLE, Fla. (February 11, 2019) – As a trusted source of information for clinical endocrinologists and other healthcare professionals, the American Association of Clinical Endocrinologists (AACE) announced today, the launch of the AACE Bone Resource Center – the fourth in a series of online educational resources available to AACE members and other medical professionals.


Dietary supplements often are sold on the promise that they will strengthen bones or even prevent osteoporosis. However, according to a new position statement released today by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE), the current understanding of the benefits of dietary supplements on bone health are inconclusive and require further studies.


When it comes to treating women with menopause, one size doesn’t fit all, says Dr. Rhoda H. Cobin, lead author of a new Position Statement on Menopause—2017 Update, published in the July 2017 issue of Endocrine Practice, by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE).  


The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016 Update and Algorithm were published in September 2016. Most recently, the American College of Physicians (ACP) published new osteoporosis guidelines, and although AACE/ACE commends the ACP effort  in addressing the importance of identifying and managing osteoporosis and fracture risk in postmenopausal women and older men, important differences from the AACE/ACE guidelines need to be clarified.


As a means to revolutionize the diagnosis, treatment and management of one of the world’s most menacing chronic diseases – obesity, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) released a bold statement that redefines the medical diagnostic term of obesity – a disease with which more than one-third (36.5 percent) of U.S. adults have been diagnosed, according to the Centers for Disease Control and Prevention (CDC).


The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) today announced the publication of new clinical practice guidelines and an accompanying algorithm to assist physicians and other medical professionals with the diagnosis, fracture risk assessment and treatment of postmenopausal osteoporosis patients.


The American Association of Clinical Endocrinologists (AACE), in conjunction with the American College of Endocrinology (ACE), today announced the publication of its 2016 update of the AACE/ACE Comprehensive Diabetes Management Algorithm and Executive Summary as a clinical guide for physicians managing the care of patients with type 2 diabetes (T2D).


A pivotal piece of legislation intended to benefit patients with diabetes and other metabolic, autoimmune and insulin-resistant diseases is headed to the floor of the House of Representatives for a vote after its passage today by the House Energy and Commerce Committee.


A consensus conference convened by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) this past weekend advocated for expanded use of continuous glucose monitoring (CGM) in the management of diabetes.


Aiming to revolutionize the diagnosis, treatment and management of obesity, one of the world’s most insidious chronic diseases, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) today released a bold position statement that redefines the medical diagnostic term for obesity as a far-reaching, complications-centric chronic disease state whose measurement goes beyond the traditional singular focus on Body Mass Index, or BMI.


Citing glycemic measurement as an essential component of care for all patients with diabetes, the American Association of Clinical Endocrinologists (AACE) today announced the publication of its outpatient glucose monitoring consensus statement.


Citing the lack of compelling evidence connecting testosterone replacement therapy (TRT) with cardiovascular events such as heart attack and stroke, physicians representing the American Association of Clinical Endocrinologists (AACE) today issued a position statement questioning claims that testosterone replacement therapy (TRT) increases the risk of cardiovascular disease among users.


Two dedicated endocrinologists, experts in the care of patients with diabetes, have used their songwriting talents to co-write, produce, and record with a former American Idol performer and other recording artists, “Needle-Free”, an anthem of hope for patients with type1 diabetes and a message of awareness of the obstacles those patients face daily.  


Endocrine leaders of the American Association of Clinical Endocrinologists, riding on the heels of a successful and unprecedented conference held last February in San Juan, Costa Rica, are discussing the results of the successful and unprecedented conference and how it will change the delivery of health care for patients in Latin America, Mexico and the Caribbean Basin for the better.


The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) organized a gathering of U.S. and international diabetes physicians, scientists, and other experts to conduct a rigorous examination of potential issues surrounding SGLT2i (sodium-glucose cotransporter-2 inhibitors), a class of prescription medicines used to lower blood sugar in adults with diabetes, and its possible relationship to diabetic ketoacidosis (DKA).


The American Association of Clinical Endocrinologists (AACE), the leading medical organization representing more than 6,000 experts in the care and treatment of diabetes patients, today announced plans to convene a conference of U.S. and international experts to examine the issue of diabetic ketoacidosis (DKA) among patients treated with SGLT2 inhibitors, a class of medications approved for use in adults with type 2 diabetes. AACE will conduct this meeting to provide answers to questions from its membership raised in response to recent case reports and publications on the subject. 


The American Association of Clinical Endocrinologists (AACE) will convene the first-ever, Pan-American Scientific Symposium: Clinical Endocrinology in Latin America on February 26-28 in San Jose, Costa Rica.


Responding to requests from its international members to adapt medical guidelines and best-practice treatment algorithms to be more applicable for use in their home countries, the American Association of Clinical Endocrinologists (AACE) just concluded a first-of-its-kind conference where the foundation was laid to achieve culturally maximized quality of endocrine care for patients across and within all borders.


An estimated 29.1 million Americans (almost 10 percent of the total population) have diabetes, another 86 million citizens aged 20 or older suffer from prediabetes, and spending on diagnosed diabetes has increased 41 percent over five years, according to the Centers for Disease Control and Prevention (CDC).


In conjunction with January being Thyroid Awareness Month, the American College of Endocrinology (ACE) – the educational and scientific arm of the American Association of Clinical Endocrinologists (AACE) – has kicked off a year-long campaign to help people understand the importance of their thyroid, a butterfly-shaped endocrine gland located low in the front of the neck.


The American Association of Clinical Endocrinologists (AACE) today announced the publication of new, expansive diabetes clinical practice guidelines and an updated diabetes algorithm to assist clinical caregivers with the medical management of patients with diabetes mellitus (DM).


The American Association of Clinical Endocrinologists (AACE) today announced its Consensus Conference on Continuous Glucose Monitoring (CGM) slated for Saturday, February 20, 2016 at the Hyatt Regency Capitol Hill in Washington, D.C.


The American Association of Clinical Endocrinologists (AACE) secured approval of a resolution by the American Medical Association (AMA) House of Delegates that will that will secure  the study of obesity education in medical schools and the develop recommendations to address gaps in obesity education to physicians.


The American Association of Clinical Endocrinologists (AACE) has launched a new, online-only journal – AACE Clinical Case Reports (AACR) – dedicated to endocrine practice case reports, including commentary from noted endocrinology experts.


Most people wouldn’t equate a dentist office visit with being adiabetes diagnosis, but according to research presented today at the American Association of Clinical Endocrinologists’ 24th Annual Scientific and Clinical Congress that’s one of the most logical places to be screened for the chronic disease.


While agreeing with the U.S. Preventive Services Task Force’s (USPSTF) assessment that more studies are needed to determine the effectiveness of screening for thyroid disease, the American Association of Clinical Endocrinologists (AACE), the nation’s largest collection of clinical endocrinologists, contends that aggressive case finding is an appropriate alternative in patient groups where thyroid risk factors are present.


The blood glucose monitoring initiative will be uniquely structured to gather input from all major stakeholders involved in the diabetes arena and will examine critical factors such as regulatory challenges, post-FDA-approval monitoring of safety and accuracy of glucose strips, glucose sensors and devices, patient access and economic/reimbursement issues.


The commentary, entitled “Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology,” examines two so-called “molecular marker” tests utilized as an adjunct to fine-needle aspiration (FNA) biopsies in assessing the malignancy risk of thyroid nodules that have been classified as “indeterminate” via FNA, with the goal of providing physicians with a practical assessment of the tests’ value as a diagnostic tool.


The National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) calls for the creation of a public/private commission of diabetes stakeholders whose purpose is to ensure the coordination of diabetes care activities that are currently managed by three dozen federal departments and agencies and to recommend new approaches to improve diabetes care.


Anthony Keith Cryar, M.D., F.A.C.E., E.C.N.U has completed all requirements for the Endocrine Certification in Neck Ultrasound (ECNU) Program administered by the American Association of Clinical Endocrinologists (AACE).


ENDO360 meets the need of organizations that wish to conduct studies solely on endocrine- related diseases including thyroid, diabetes, osteoporosis, hormone deficiencies, obesity and more.


The AACE/ACE Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action will convene March 23-24, 2014 in Washington, D.C.  This conference is uniquely structured to consider research, information and opinions from all major stakeholders involved in the obesity arena. 


A thyroid cancer survivor who was diagnosed and treated for the condition at age 27, Sackhoff will be joining nationally recognized thyroid expert and AACE member Dr. Jeffrey Garber for television appearances to advance knowledge about thyroid disease.


The position statement is the outgrowth of AACE/ACE’s March 2014 AACE/ACE Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action, which convened in Washington, D.C. to identify the myriad of issues surrounding the obesity epidemic and generate a meaningful, medically actionable and economically viable model for diagnosis and treatment of obesity as a disease state.


In 2011, the American Association of Clinical Endocrinologists (AACE) Board of Directors declared obesity a disease state. And in 2013, the American Medical Association (AMA) agreed, approving an AACE-sponsored resolution on the floor of its House of Delegates. While many understood this to be a pivotal moment in the battle to curtail and reduce historic obesity rates, the question then heard most often was, “What happens next?”


In recent years, medical journals and consumer publications alike have been hashing out the controversy about salt consumption and its effects on an array of medical conditions, primarily high blood pressure and heart disease, but also osteoporosis, kidney stones and kidney disease, and obesity.


We are very pleased that the expanded USPSTF guidelines are now more aligned with our organization’s clinical guidelines


A thyroid cancer survivor who was diagnosed and treated for the condition at age 27, Sackhoff will be joining nationally recognized thyroid expert Dr. Jeffrey Garber for a satellite media tour


A local non-profit association of physicians who specialize in diabetes research, treatment and care is urging news anchors in Jacksonville to participate in World Diabetes Day


JACKSONVILLE, Fla. – (February 12, 2014) – If you’re looking to show the man or lady of your dreams some loving with a sweet treat this Valentine’s Day, you’re not alone: the National Confectioners Association reports that 69 percent of Americans prefer gifts of confections over flowers on Valentine’s Day, with an estimated $1.6 billion spent on candy for the occasion.


Bhatt DL, Steg G, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380:11-22.

https://www.nejm.org/doi/full/10.1056/NEJMoa1812792


Treatment of hypercholesterolemia with statins results in significant reductions in cardiovascular risk; however, individuals with well-controlled low-density lipoprotein cholesterol (LDL-C) levels, but persistent high triglycerides (TG), remain at increased risk.


Shin J, Chung JW, Jang HS et al. Achieved low-density lipoprotein cholesterol level and stroke risk: A meta-analysis of 23 randomised trials. Eur J Prev Cardiol 2019:2047487319830503.

http://www.ncbi.nlm.nih.gov/pubmed/?term=30782002


Fogacci F, Banach M, Mikhailidis DP et al. Safety of Red Yeast Rice Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmacol Res. 2019; 143:1-16.

http://www.ncbi.nlm.nih.gov/pubmed/?term=30844537


Ference BA, Ray KK, Catapano AL, et al. Mendelian Randomization Study of ACLY and Cardiovascular Disease.


Ray KK, Bays HE, Catapano AL, et al. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. N Engl J Med. 2019;380:1022-1032.

https://www.nejm.org/doi/full/10.1056/NEJMoa1803917


An estimated 30.3 million Americans have type 2 diabetes (T2D), a complex, progressive disease that requires intensified treatment over time.1-3 The complexity of T2D management, coupled with the need to tailor treatment recommendations to individual patients, presents an ongoing clinical challenge. The number and variety of treatment options available for T2D has increased dramatically in the last 15 years, with several new drug classes emerging as safe and effective.2,4,5


A preliminary slate of candidates for the election of Officer positions for a one-year (1) term, five (5) open positions on the Board of Directors for election to a three-year (3) term (2019-2022) and one (1) open position on the Board of Directors for a one-year (1) term (2019-2020) to fill the unexpired term of Dr. Sethu Reddy, who was elected Secretary in 2018, was sent to the membership via email/fax on December 28.


Horizon Reimbursement Policies effective February 25, 2019 will be applied to professional claims for services provided to patients enrolled in fully insured groups and ASO groups that opted in to policy guidelines. Diabetic screening services, duplicate claim logic for independent lab services, lab services billed by physicians are just a few of the policies that may affect endocrinologists. We strongly encourage you to review the content of each policy.

2019 Training Materials for Part D Opioid Policies.